StreetAlpha
13F holdings · Q3 2026

First Light Asset Management

Edina, MN · files as First Light Asset Management, LLC
Know the moment First Light Asset Management filesYou follow First Light Asset Management An email or push as soon as its next 13F reaches the SEC, with every stock it bought, sold and trimmed. Next 13F due by Feb 15, 2027
Filed
Holdings as of Sep 30, 2026Filed Nov 16, 2026Next filing due Feb 15, 2027CIK 1600004

First Light Asset Management reported 32 stocks worth $1.7B in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are AXGN (9.3%), NEO (9.2%) and SIBN (8.6%). Compared with Q2 2026, the fund opened new positions in VERA, INSP and BBNX, added to AXGN, AMLX and EWTX, trimmed NEO, SIBN and PVLA and sold out of OMCL and TCMD.

Latest filing: what First Light Asset Management did in Q3 2026

vs Q2 2026
Filed 13F-HRView on SEC ↗
5 new11 added16 trimmed4 sold outBought about $312M · sold about $420M
New 5
Added 11
See all 11 →
Trimmed 16
See all 16 →
Sold out 4
  • Apogee Therapeutic$123M
  • Crinetics Pharmace$50.9M
  • OMCL$18.8M
  • TCMD$13.8M

Dollar changes use the share change at the quarter end price. New and sold out show the whole position.

Reported value$1.7B+2.5% vs last quarter
Stocks held325 new · 4 sold out
Top 5 weight39.9%fairly concentrated
Turnover43%of the portfolio changed

Portfolio at a glance

share of reported value · Q3 2026
🔒 A free account shows every holding, what the fund sold and its options.Create free account

Holdings

#StockValueWeightSharesChangeShares, 8 qtrsHeld
1
AXGN
Axogen Inc
$157M9.3%3.7M+989K (+36%)8 of 8
2
NEO
Neogenomics Inc
$155M9.2%8.5M−3.8M (−31%)8 of 8
3
SIBN
Si-Bone Inc
$145M8.6%7.7M−441K (−5%)8 of 8
4
AMLX
Amylyx Pharmaceuticals Inc
$116M6.9%4M+963K (+32%)5 of 8
5
PVLA
Palvella Therapeutics Inc NE
$101M6.0%734K−38K (−5%)5 of 8
6
EWTX
Edgewise Therapeutics Inc
$101M6.0%2.5M+1.4M (+127%)8 of 8
7
TWST
Twist Bioscience Corp
$83.2M4.9%430K−298K (−41%)8 of 8
8
MASS
908 Devices Inc
$82M4.9%6.6M+358K (+6%)7 of 8
9
GH
Guardant Health Inc
$78.1M4.6%438K−3,704 (−1%)8 of 8
10
VERA
Vera Therapeutics Inc
$63.3M3.8%2MNew position7 of 8
🔒 22 more holdings in this filing. Create a free account or sign in to see them all.

Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.

Sold out

held in Q2 2026, gone in Q3 2026
StockValue last quarterShares sold
APOGEE THERAPEUTICS INC
$123M930K
CRINETICS PHARMACEUTICALS IN
$50.9M1.4M
OMCL
Omnicell Com
$18.8M452K
TCMD
Tactile Sys Technology Inc
$13.8M463K

Reported value

last 8 quarters
$1BQ4 '24
$876MQ1 '25
$771MQ2 '25
$1.1BQ3 '25
$1.3BQ4 '25
$1.1BQ1 '26
$1.6BQ2 '26
$1.7BQ3 '26

The value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.

Filings for Q3 2026

straight from the SEC
FiledFormQuarter
Nov 16, 202613F-HRQ3 2026SEC filing ↗

Other superinvestors

All hedge fund holdings →

First Light Asset Management 13F FAQ

What does First Light Asset Management own?

First Light Asset Management reported 32 stocks worth $1.7B in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are AXGN (9.3%), NEO (9.2%) and SIBN (8.6%). The table above lists every position in the filing (the top 10 without an account).

What did First Light Asset Management buy and sell in Q3 2026?

Compared with Q2 2026: 5 new positions, 11 added to, 16 trimmed and 4 sold out. New positions include VERA, INSP and BBNX. It sold all of OMCL and TCMD.

When will First Light Asset Management file its next 13F?

Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.

How much is First Light Asset Management's portfolio worth?

The Q3 2026 filing reports $1.7B in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.